Table I.
Name | Sense | Antisense |
---|---|---|
GAPDH | TGCCGTCTAGAAAAACCTGC | ACCCTGTTGCTGTAGCCAAA |
p18 | CCTGATCGTCAGGACCCTAA | TTATTGAAGATTTGTGGCTCC |
p21 | CACCCTAGTTCTACCTCAGGCA | ACTCCCCCATCATATACCCCT |
p27 | ACGGGAGCCCTAGCCTGGAGC | TGCCCTTCTCCACCTCTTGCC |
p53 | TGGCCATCTACAAGCAGTCACA | GCAAATTTCCTTCCACTCGGAT |
Cyclin B | CCATTATTGATCGGTTCATGCAGA | CTAGTGGAGAATTCAGCTGTGGTA |
Cyclin D | GGATGCTGGAGGTCTGCGAGGAAC | GAGAGGAAGCGTGTGAGGCGGTAG |
Cyclin E | GGAAGGCAAACGTGACCGTT | GGGACTTAAACGCCACTTAA |
CDK2 | TTTCTGCCATTCTCATCGG | CTTGGCTTGTAATCAGGCATAGA |
Fas | ACTTGGGGTGGCTTTGTCTT | GGATGATAGTCTGAATTTTCTCTG |
FasL | GCCTGTGTCTCCTTGTGA | GCCACCCTTCTTATACTT |
TRAILR1 | AGAGGGATGGTCAAGGTCAA | GAGTCAAAGGGCACGATGTT |
TRAIL | AGTCTCTCTGTGTGGCTGTA | TGTCTATCAAGTGCTCATTT |
Bax | AAGAAGCTGAGCGAGTGT | GGAGGAAGTCCAATGTC |
FLIP | AATTCAAGGCTCAGAAGCGA | GGCAGAAACTCTGCTGTTCC |
Bcl-2 | GTGGAGGAGCTCTTCAGGGA | AGGCACCCAGGGTGATGCAA |
CDK, cyclin dependent kinase; FasL, Fas ligand; TRAIL, tumor necrosis factor-related apoptosis-inducing ligand; TRAILR, TRAIL receptor; Bax, Bcl-2 associated X.